![Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9: Molecular Therapy - Methods & Clinical Development Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/774d06b8-fec4-42e1-8d9b-3f4b963c4202/fx1_lrg.jpg)
Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9: Molecular Therapy - Methods & Clinical Development
Application Note 85 AAV Purification Purification of Adeno-associated Virus (AAV) Vectors Using Norgen's AAV Purification Kit
![Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies: Molecular Therapy - Methods & Clinical Development Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/db67268c-043e-4061-99c9-a426e0dbd180/fx1.jpg)